M ore than 2 million women in the United
States are either undergoing active treatment or have completed treatment for breast cancer. Despite the established efcacy of breast cancer treatments such as chemotherapy and radiation, they have adverse efects on patients' cardiovascular, metabolic, and quality-of-life (QoL) outcomes. Some adverse efects can be acute, occurring primarily during treatment, whereas others may have a delayed onset and persist for years after the cessation of treatment. Moreover, it seems that the mode of treatment a patient receives may determine the magnitude and variability of these side efects. 1 For example, chemotherapy often leads to nausea, vomiting, depression, 2 reduced bone-mineral density, 3 and cardiac toxicity. 4 Cancer-related fatigue has been reported in patients who undergo chemotherapy with or without radiotherapy. 2 Radiation has been linked with cardiac toxicity and damage to surrounding organs from unintentional irradiation. 4, 5 Furthermore, the use of these treatments sequentially may result in more pronounced acute toxicity and fatigue. 6 It is becoming more widely recognized that exercise is an important intervention in the multidisciplinary management of breast cancer. Moreover, exercise can play an important role in preserving ftness and function across the survivorship continuum. 7 However, if exercise is to be established as a standard of cancer care, there is a need for clarity in the evidence supporting the safety and efcacy of exercise interventions during diferent types of treatment. To date, most research has focused on post-treatment care and the restoration of function. Indeed, several review articles have summarized the benefts of exercise after treatment in breast cancer patients. [8] [9] [10] [11] However, given that the adverse efects are substantially more pronounced during treatment, an assessment of the safety and efcacy of exercise during primary treatment is warranted. Furthermore, since the severity of side efects may be dependent on the type of treatment, it is important clinically to evaluate the efects of exercise during diferent types of breast cancer treatment.
Te purpose of this systematic review of the efects of exercise interventions during chemotherapy and radiation in breast cancer patients is to present and evaluate the results of randomized controlled trials (RCTs) conducted in this area to date. In addition, we aim to provide an estimation of the magnitude of the change in outcomes using Cohen's d efect sizes Previous fndings suggest that exercise is a safe and effcacious means of improving physiological and psychosocial outcomes in female breast cancer survivors. To date, most research has focused on post-treatment interventions. However, given that the type and severity of treatment-related adverse effects may be dependent on the type of treatment, and that the effects are substantially more pronounced during treatment, an assessment of the safety and effcacy of exercise during treatment is warranted. In this review, we present and evaluate the results of randomized controlled trials (RCTs) conducted during breast cancer treatment. We conducted literature searches to identify studies examining exercise interventions in breast cancer patients who were undergoing chemotherapy or radiation. Data were extracted on physiological and psychosocial outcomes. and to summarize recruitment, retention, adherence, and overall methodological quality of the interventions.
Methods

Inclusion criteria
Studies were included in the review if they examined exercise during chemotherapy or radiation for breast cancer and were published in English. In accordance with previous literature, interventions during therapy were defned as those that began with or after the initiation of treatment and concluded either 1 week after the last radiation treatment, 3 weeks after the last intravenous chemotherapy treatment, or 3 weeks after the cessation of chemotherapy. 12, 13 Also included were studies that used interventions aimed at improving cardiovascular endurance, or muscular strength and endurance. Interventions that used alternative techniques such as yoga or tai-chi, were also included. For the purposes of this study, only RCTs that allowed for efect sizes to be calculated were included.
Study selection and data abstraction
We performed computer and manual searches following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).
14 An original search of titles and abstracts in PubMed and MEDLINE databases was conducted in October 2014. A subsequent search was conducted in April 2015 to ensure inclusion of any additional published manuscripts. Search terms including exercise (physical activity, weight training, resistance exercise, cardiovascular training, rehabilitation, aerobic, yoga) and cancer treatment (primary therapy, therapy, cancer treatment, chemotherapy, radiation, hormonal therapy) were entered in diferent combinations. In accordance with PRISMA guidelines, a summary of the results of the computerized search was outlined (Figure) . Manual searches were conducted using reference lists of previous reviews and metaanalyses of the exercise oncology literature.
Data synthesis
Quantitative efect size calculations were used to synthesize the results from the interventions included in the present review. Quantitative synthesis was conducted using Cohen's d efect sizes. Tese were either obtained directly from the studies themselves, or calculated using statistical information provided in the study. Cohen's d efect sizes are classifed as: small, 0.20; moderate, 0.50; and large, 0.80. Efect sizes were calculated by taking the diference of the mean values obtained at baseline and follow-up assessments and dividing by the pooled standard deviation. For the purpose of this review, positive efect sizes indicated an improvement in outcomes and negative efect sizes represented unfavorable changes in an outcome. Specifc outcomes of interest were QoL, fatigue, and various performance/functional outcomes (aerobic capacity, strength, and so on). Study quality was assessed by 2 independent freviewers (CMF, BCF) using the Delphi list for evaluation of the quality of RCTs. 15 Each item was rated Yes or No based on the methods reported in each study. Studies that did not provide methodological information that directly addressed a particular quality indicator were recorded as not having met that indicator in the evaluation. Given that there is presently no validated summary scoring system for the Delphi criteria list, the number of indicators met by each of the studies included in the systematic review was tabulated.
Results
Study characteristics
A total of 17 studies involving 1,175 participants met the inclusion criteria of this review (Table 1) . Sample sizes ranged from 20-242 participants. Te resistance exercise (RE) intervention characteristics included a range of 1-3 sets of 8-12 repetitions at training loads ranging from 40%-80% 1 repetition maximum (1RM), lasting from 12 weeks to 6 months. Te aerobic exercise (AE) intervention characteristics included training intensities ranging from 50%-80% age-predicted maximal heart rate (APM HR), for 10-60 minutes, 3-6 days a week, lasting from 6 weeks to 6 months. Combined interventions included a combination of aerobic and resistance training. Specifc details about these interventions were not reported in the studies.
Recruitment, retention, and adherence rates A summary of the recruitment, retention, and adherence rates are reported in Table 1 . For 11 of the 17 studies, an average of 53% (range, 15%-95%) of eligible Review participants screened for inclusion, were enrolled for the trials. Retention rates (participants who completed baselines and post assessments) averaged 86% (range, 55%-100%). Of the 17 studies, 6 did not report adherence to the interventions. Adherence (attendance to each exercise session) for the remaining interventions was 71% (range, 58%-95%).
Methodological quality assessment A summary of the methodological assessment is presented in Table 2 . Overall, the studies met an average of 64% of the quality indicators (range, 43%-86%). Te most commonly observed problems were a lack of intent-to-treat analysis, testing not conducted by blinded evaluators, and lack of concealment of treatment allocation. Notable methodological strengths of the RCTs were specifcity of eligibility criteria, similarity of key outcomes at baseline, and consistent reporting of relevant descriptive statistics.
Summary of exercise interventions by treatment type and mode of exercise
A brief summary of each study's sample, outcome assessments, and feasibility measures, and their accompanying efect sizes are outlined in the following section. Te studies are organized by type of treatment and mode of exercise. A summary of the efect size changes in the outcomes of each trial is provided in Table 3 . 
Chemotherapy
22,23,24
Combined exercise interventions. Only 1 trial examined the efects of a combined exercise intervention during chemotherapy. Specifcally, in a 2-arm randomized controlled trial, HusebØ and colleagues compared patients in a home-based exercise (resistance and aerobic) intervention for the duration of chemotherapy with those in a usual-care group in a total of 67 breast cancer patients. 25 Of 92 eligible participants, 67 (76%) were enrolled in the study, and 64 participants completed 6-month follow-up. Adherence to the exercise intervention was 58%. Assessments of fatigue (using the 6-item Schwartz Cancer Fatigue Scale), physical activity (International Physical Activity Questionnaires) and physical ftness (6MWT or 6-minute walk test) were obtained at baseline, end of chemotherapy, and 6-month follow-up. Tere was a signifcant increase in fatigue at end of chemotherapy (d = -.41), with a return to baseline at 6-month follow-up (d = .02), while there was a negligible change in 6MWT (d = .20) and MET (d = .18) at end of chemotherapy with a signifcant improvement at 6-month follow-up (6MWT, d = .31; MET, d = .43). Tere were 2 nonserious adverse events related to the intervention with 1 account of knee pain, and another due to syncope from a secondary chronic condition.
Alternative modes of exercise interventions. No study that met our inclusion criteria focused specifcally on alternative modes of exercise, such as yoga, during chemotherapy alone.
Radiation AE interventions.
No studies that met our inclusion criteria focused specifcally on AE during radiation treatment alone.
RE interventions.
No studies that met our inclusion criteria focused specifcally on RE during radiation treatment alone AE and RE interventions. No studies that met our inclusion criteria focused specifcally on AE and RE during radiation treatment alone Combined exercise interventions. Only 1 trial examined the efect of a combined exercise intervention during radiation treatment. Hwang and colleagues conducted a 2-arm randomized controlled trial to examine the efcacy of a 5-week supervised exercise intervention in 40 breast cancer patients undergoing radiotherapy. 26 Assessments of QoL, fatigue (BFI), range of motion (RoM) of the shoulder, and pain were obtained at baseline and 5-week followup. Recruitment to the study was not reported. In all, 37 of the 40 enrolled (92.5%) completed baseline and followup assessments. No adverse events related to the intervention were reported. Te descriptive statistics necessary to calculate efect sizes for fatigue, RoM, and pain were not provided. However, the exercise intervention resulted in an improvement in overall QoL (d = .63).
Alternative modes of exercise interventions. Two studies were included examining the efects of yoga in breast cancer patients undergoing radiation. Both interventions lasted 2 weeks. Te number of participants who completed baseline and follow-up assessments were 56 and 132 respectively. Adherence to either intervention wasn't reported. No adverse events related to the interventions were reported. Combined AE and RE exercise. No studies meeting the inclusion criteria focused specifcally on combined exercise during mixed combination therapy.
Alternative modes of exercise interventions. No studies meeting the inclusion criteria focused specifcally on alternative exercise (eg, yoga) during mixed combination therapy.
Synthesis of overall interventions during combination therapy. One intervention examined RE during mixed therapy, yielding improvements in muscular strength 
Discussion
Te purpose of this review was to systematically evaluate of the efcacy of implementing exercise interventions in the adjuvant treatment of breast cancer patients undergoing diferent modes of primary therapy. Te results indicate that AE alone, RE alone, interventions combining aerobic and resistance exercise, as well as alternative modes of exercise (eg, yoga) are safe, well-tolerated lifestyle interventions that can not only attenuate many of the adverse efects accompanying treatment, but can yield signifcant, clinically meaningful improvements in select ftness, physiological, and patient-reported outcomes (PROs) in breast cancer patients who are undergoing cancer treatment. Tese fndings are consistent with those of other studies of exercise in breast cancer patients [7] [8] [9] and they provide evidence supporting the safety and utility of integrating exercise as a supportive-care intervention for breast cancer patients undergoing diferent types of active treatment.
Te most consistently assessed outcomes across the trials were disease specifc QoL and PROs such as mood, depression, and anxiety. Results revealed that irrespective of the type of exercise, interventions yielded comparable, small-to-moderate efect size improvements in both disease-specifc indices of QoL and PROs. We view the observation that various modes of exercise yielded similar improvements in key PROs during breast cancer treatment as a promising fnding because it provides oncologists and health/ftness professionals multiple options when considering implementing exercise as a supportive-care approach during breast cancer treatment. We also contend this fnding provides the opportunity to better personalize the exercise modality to patients' individual exercise capacity, tolerance, and preference, which could augment the utility of integrating exercise as an approach for managing adverse efects that often accompany active breast cancer treatment.
Although the dearth of studies precludes a comprehensive evaluation of the comparable efcacy of various modes of exercise during diferent primary breast cancer treatments, there were several particularly relevant benefts accompanying exercise during specifc types of primary breast cancer treatment that warrant attention. For example, RE elicited the most pronounced improvements in body composition observed across trials during chemotherapy. Furthermore, the clinically meaningful improvements in select cardiovascular outcomes accompanying AE during both chemotherapy and the combination of radiation and chemotherapy was also notable. It has been well established that chemotherapy is associated with signifcant decline in cardiovascular function and unfavorable change in body composition among breast cancer patients. Te clinically meaningful benefts highlight the potential utility of integrating these modes of exercise as supportive care approaches for breast cancer patients undergoing chemotherapy or the combination of chemotherapy and radiation.
Another particularly relevant fnding was the efects of RE and combined aerobic and RE on fatigue observed during the combination of radiation and chemotherapy. Notably, whereas RE resulted in signifcant improvement in fatigue, an intervention combining aerobic and RE did not yield Review favorable change in fatigue during the combination treatment. Although this fnding may represent an important diference in the efects of exercise on fatigue symptoms of breast cancer patients during combination therapy, the limited number of studies makes such conclusions premature. Nonetheless, given the profound impact of fatigue symptoms on QoL of patients during breast cancer treatment, this fnding underscores the critical need to further evaluate the extent to which RE alone, AE alone, and interventions combining these modes of exercise may yield a unique trajectory of change in fatigue during active breast cancer treatment.
Te improvements in multiple relevant PROs around yoga are also noteworthy. Yoga was consistently associated with moderate-to-large efect size improvements in patients' self-reported mood, stress, and QoL. Tese fndings suggest that yoga may be a particularly benefcial supportive-care intervention for managing the distress that is often reported by breast cancer patients during active treatment. In addition, yoga may also represent an alternative form of exercise for many breast cancer patients with limited tolerance or capacity to perform traditional aerobic and/or RE prescriptions.
A prominent observation of this review is the considerable variability in the quality of the interventions. On average, studies met 4 of the 7 Delphi quality indicators (range, 2-6). Based on the percentage of Delphi quality indicators met across the included RCTs, the methodological quality of exercise intervention studies in breast cancer patients undergoing diferent primary treatments can be classifed as moderate. Accordingly, the methodological rigor of future exercise intervention trials targeting breast cancer patients during active treatment should be improved with additional focus on key design considerations such as inclusion of blinded evaluation of key outcomes, concealment of treatment allocation, and intent-to-treat analyses.
Moreover, there was a large degree in variability in the exercise testing and prescription during these trials. For instance, measures of aerobic capacity included VO 2 max, VO 2 peak, 6MWT and 12MWT. Consequently, the lack of specifcity makes the pooling and aggregation of data difcult. Tere was a large variability in the exercise prescription with diferent times, intensities, and overall duration being prescribed. Tis variation makes it difcult to conclude a dose-response efect of exercise during cancer therapy. Overall, there is a glaring need for standardization of methods of assessment, and exercise prescription to improve clarity on the role of exercise interventions during primary therapy for breast cancer patients.
It should be acknowledged that our approach to quantitatively evaluating the efects of exercise during diferent treatments using calculation of efect sizes is not as robust as conducting meta-analytic procedures that systematically adjust for bias in the efect size estimate. However, given the limited number of randomized controlled studies evaluating exercise during diferent breast cancer treatments, we believe the present approach represents an important frst step in synthesizing the efects of exercise during multiple breast cancer treatments. As this area of inquiry expands, future reviews incorporating standardized metaanalytic procedures will allow for a more comprehensive assessment of the potential diferential efects of exercise during diferent primary breast cancer treatments.
It has been suggested that for the feld of exercise oncology to progress, there is a need for researchers to increase our understanding of how exercise can afect cancer variables (treatment completion rate, tumor biology, disease outcomes, and so on). To date, only 1 study has examined treatment completion rates in breast cancer patients, with an approximate 5% improvement in chemotherapy completion rate among breast cancer patients engaging in resistance training. 22 Although these initial results are promising, future research is needed in this area to determine the efect of exercise on treatment response as an outcome to fully elucidate its efcacy.
Delineating the extent to which the various modes of exercise may be of particular beneft during chemotherapy, radiation therapy, or the sequential combination of these treatments, would be of considerable importance in refning exercise prescription approaches during active breast cancer treatment. Consistent with this position, it is critical to develop consistency in the assessment of key clinical, ftness, and PROs across trials in order to advance understanding of best practices in implementing exercise during primary breast cancer treatment. Finally, the extent to which personalizing the exercise prescription to the individual exercise tolerance, capacity, and preferences of patients during breast cancer treatment is also critical in determining the efcacy of implementing exercise as an efective adjuvant supportive care intervention.
In summary, this is one of the frst systematic reviews to evaluate the comparable efcacy of exercise as a supportive care intervention during diferent primary breast cancer treatments. Te fndings demonstrate that exercise is a safe, feasible intervention that yields signifcant, clinically meaningful improvements in relevant ftness, physiological, and patient reported outcomes in breast cancer patients undergoing diferent treatment. Despite these promising fndings, the limited number of studies specifcally addressing the diferent modes during each type of treatment limits the ability to adequately assess the comparable efcacy of the various exercise modes during established primary breast cancer treatments. Accordingly, additional research that systematically evaluates the potential unique benefts that various modes of exercise may ofer women while undergoing diferent primary breast cancer treatment is warranted to help guide the oncologists and health/ftness professionals in implementing exercise as a supportive care intervention for breast cancer patients.
